Revance Therapeutics, Inc. lèt majiskil
Revance Therapeutics, Inc. majiskil sou entènèt jodi a an dola. Revance Therapeutics, Inc. lèt majiskil, sa vle di kantite aksyon eksepsyonèl miltipliye pa pri a pataje, yo montre. Sa a se enfòmasyon referans sou majiskil Revance Therapeutics, Inc.. Revance Therapeutics, Inc., majiskil - 2 767 891 456 dola ameriken.
Revance Therapeutics, Inc. volim nan komès
Revance Therapeutics, Inc. komès komès jodi a = 401 531 dola ameriken. Revance Therapeutics, Inc. se tablo volim komès prezante sou sit entènèt la chak jou. Revance Therapeutics, Inc. komès holds sou anpil echanj valè echanj nan tan reyèl, nou montre volim komès la chak jou nan Revance Therapeutics, Inc.. Revance Therapeutics, Inc. kap mache diminye pa $ -50 310 400.
|
Revance Therapeutics, Inc. mache bouchon tablo
Revance Therapeutics, Inc. lèt majiskil sou yon graf pa ane. 4.76% - yon chanjman nan lèt majiskil sou mache Revance Therapeutics, Inc. pou chak semèn. Revance Therapeutics, Inc. chanjman majiskil pou ane a se 3.71%. Revance Therapeutics, Inc. kap mache pi gran yè.
| Semèn | Mwa | 3 mwa | Ane | 3 zan |
Revance Therapeutics, Inc. Istwa kapitalizasyon
| Dat |
Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
|
|---|---|
| 04/05/2023 | 2 767 891 456 $ |
| 03/05/2023 | 2 818 201 856 $ |
| 02/05/2023 | 2 764 537 856 $ |
| 01/05/2023 | 2 707 519 744 $ |
| 28/04/2023 | 2 668 948 480 $ |
| 27/04/2023 | 2 612 769 024 $ |
| 26/04/2023 | 2 642 116 608 $ |
Revance Therapeutics, Inc. tablo volim
| Semèn | Mwa | 3 mwa | Ane | 3 zan |
Revance Therapeutics, Inc. done istwa volim
| Dat |
Volim (24h)
Volim komèsyal de aksyon Revance Therapeutics, Inc. se kantite total tout tranzaksyon ak aksyon RVNC achte ak vann pandan dat la chwazi a.
|
|---|---|
| 04/05/2023 | 401 531 $ |
| 03/05/2023 | 1 214 478 $ |
| 02/05/2023 | 554 346 $ |
| 01/05/2023 | 729 833 $ |
| 28/04/2023 | 605 022 $ |
| 27/04/2023 | 410 754 $ |
| 26/04/2023 | 874 686 $ |
Revance Therapeutics, Inc. majiskil nan 04/05/2023 montan pou 2 767 891 456 dola ameriken. Revance Therapeutics, Inc. majiskil nan 03/05/2023 montan pou 2 818 201 856 dola ameriken. Revance Therapeutics, Inc. majiskil nan 02/05/2023 egal a 2 764 537 856 dola ameriken. Revance Therapeutics, Inc. majiskil montan pou 2 707 519 744 dola ameriken nan 01/05/2023.
Lèt majiskil sou mache Revance Therapeutics, Inc. nan 28/04/2023 montan pou 2 668 948 480 dola ameriken. Revance Therapeutics, Inc. majiskil nan 27/04/2023 egal a 2 612 769 024 dola ameriken. Revance Therapeutics, Inc. majiskil montan pou 2 642 116 608 dola ameriken nan 26/04/2023.
Lèt majiskil Revance Therapeutics, Inc. jodi a se 2 767 891 456 $. Kapitalizasyon sou mache a nan Revance Therapeutics, Inc. te chanje a -1.785% konpare ak yè. Volim komèsyal de aksyon RVNC nan Revance Therapeutics, Inc. nan dènye jou komès montan pou 401 531 $. Volim komèsyal de aksyon de Revance Therapeutics, Inc. chanje pou -66.938% konpare ak jou komès anvan an.